Media

Conference

Safety & Recalls
Regulatory Updates
Drug Coverage
COPD
Cardiovascular
Obstetrics-Gynecology & Women's Health
Ophthalmology
Clinical Pharmacology
Pediatrics
Urology
Pharmacy
Idiopathic Pulmonary Fibrosis
Diabetes and Endocrinology
Allergy, Immunology, and ENT
Musculoskeletal/Rheumatology
Respiratory
Psychiatry and Behavioral Health
Dermatology
Oncology

The guideline development process: One organization's experience with a guideline for stable COPD (PDF)

August 1, 2002

Article

Finding optional ways to manage patients with chronic obstructive pulmonary disease (COPD) - the fourth leading cause of death in the US became a priority for this large mid-western collaborative of health care organizations. This this end, a guideline was developed to help clinicians identify, evaluate and manage COPD. This article provides an overview of the guideline development process and implementation approach, key guideline components, and the step-by-step pharmacologic treatment strategy.

Related Content

Boehringer Ingelheim to Cap Out-of-Pocket Cost for Inhalers at $35

March 7th 2024

Article

Asthma Rescue Medication Airsupra is Now Available

January 22nd 2024

Article

Airsupra is an anti-inflammatory rescue medication that can treat the symptoms of asthma while helping to prevent an attack.

FDA Grants Priority Review for Sotatercept in Pulmonary Arterial Hypertension

September 28th 2023

Article

Sotatercept is a first-in-class therapy to treat the rare disease pulmonary arterial hypertension. The FDA has assigned a target action date of March 26, 2024.

FDA Accepts sNDA for Ofev in Children with Rare Lung Disease

July 25th 2023

Article

If approved, Ofev would be the first approved treatment for children and adolescents with fibrosing interstitial lung disease. A decision is expected in the fourth quarter of this year.

FDA Approves Tezspire in Pre-Filled Pen

February 3rd 2023

Article

Tezspire is a biologic that specifically targets the inflammation associated with asthma.

FDA Approves Rescue Combination Medication for Asthma

January 11th 2023

Article

Airsupra is the first rescue medication to manage both the symptoms and the inflammation associated with asthma.

Related Content

Boehringer Ingelheim to Cap Out-of-Pocket Cost for Inhalers at $35

March 7th 2024

Article

Asthma Rescue Medication Airsupra is Now Available

January 22nd 2024

Article

Airsupra is an anti-inflammatory rescue medication that can treat the symptoms of asthma while helping to prevent an attack.

FDA Grants Priority Review for Sotatercept in Pulmonary Arterial Hypertension

September 28th 2023

Article

Sotatercept is a first-in-class therapy to treat the rare disease pulmonary arterial hypertension. The FDA has assigned a target action date of March 26, 2024.

FDA Accepts sNDA for Ofev in Children with Rare Lung Disease

July 25th 2023

Article

If approved, Ofev would be the first approved treatment for children and adolescents with fibrosing interstitial lung disease. A decision is expected in the fourth quarter of this year.

FDA Approves Tezspire in Pre-Filled Pen

February 3rd 2023

Article

Tezspire is a biologic that specifically targets the inflammation associated with asthma.

FDA Approves Rescue Combination Medication for Asthma

January 11th 2023

Article

Airsupra is the first rescue medication to manage both the symptoms and the inflammation associated with asthma.

Advertise

Editorial Info

Terms & Conditions

Do Not Sell My Personal Information